Key Events This Week
27 Jan: Stock hits 52-week low at Rs.381.10 amid ongoing downtrend
27 Jan: Sharp decline in quarterly financial performance reported
28 Jan: Modest recovery with a 0.46% gain
29 Jan: Strong rebound with 2.98% increase
30 Jan: Week closes at Rs.417.95, down 1.21% for the week
27 January 2026: New 52-Week Low Amid Financial Pressures
On 27 January, Shree Ganesh Remedies Ltd’s stock plunged to a fresh 52-week low of Rs.381.10, marking a sharp intraday decline of 9.92%. The stock opened with a gap down of 7.32% and closed at Rs.400.40, down 5.35% on the day. This significant drop reflected mounting financial pressures and a deteriorating outlook within the Pharmaceuticals & Biotechnology sector. The broader market, however, showed resilience with the Sensex closing 0.50% higher at 35,786.84, highlighting the stock’s underperformance relative to the benchmark.
The company’s quarterly financial results released the same day revealed a steep decline in net sales by 21.96% to Rs.21.11 crores for the December 2025 quarter, alongside a 43.0% fall in profit after tax to Rs.3.09 crores. Interest expenses surged by 49.44% over nine months, reaching Rs.2.69 crores, further pressuring profitability. The return on capital employed (ROCE) dropped to 16.18%, signalling reduced capital efficiency. These factors contributed to the downgrade of the company’s Mojo Grade to Strong Sell with a low Mojo Score of 23.0, reflecting heightened risk and negative sentiment.
28 January 2026: Modest Recovery on Lower Volume
Following the sharp decline, the stock showed a modest recovery on 28 January, gaining 0.46% to close at Rs.402.25. This rebound occurred on relatively low volume of 3,798 shares, suggesting cautious investor participation. The Sensex continued its upward trajectory, rising 1.12% to 36,188.16, further emphasising the stock’s lagging performance within the broader market context.
Our latest weekly pick is out! This Large Cap from Steel/Sponge Iron/Pig Iron delivered with target price and complete analysis. See what makes this week's selection special!
- - Latest weekly selection
- - Target price delivered
- - Large Cap special pick
29 January 2026: Strong Rebound Amid Sector Volatility
The stock gained further momentum on 29 January, rising 2.98% to close at Rs.414.25. This marked the strongest daily gain of the week, albeit on modest volume of 3,018 shares. The Sensex edged up 0.22% to 36,266.59, maintaining its positive trend. Despite this rebound, the stock remained well below its 52-week high of Rs.950, underscoring the persistent challenges faced by the company.
Financially, the company’s earnings per share (EPS) declined to Rs.2.41, the lowest in recent quarters, reflecting the ongoing margin contraction and operational difficulties. The company’s price-to-book value ratio stands at 3.5, indicating a valuation discount relative to some peers, but this has not translated into positive investor sentiment amid the deteriorating fundamentals.
30 January 2026: Week Closes Slightly Lower Despite Market Volatility
On the final trading day of the week, 30 January, Shree Ganesh Remedies Ltd closed at Rs.417.95, up 0.89% intraday but down 1.21% for the week overall. The Sensex declined 0.22% to 36,185.03, reflecting some market volatility. The stock’s volume increased slightly to 3,908 shares, but the overall weekly trend remained negative, driven by the earlier sharp fall and ongoing financial concerns.
Holding Shree Ganesh Remedies Ltd from ? See if there's a smarter choice! SwitchER compares it with peers and suggests superior options across market caps and sectors!
- - Peer comparison ready
- - Superior options identified
- - Cross market-cap analysis
Daily Price Comparison: Shree Ganesh Remedies Ltd vs Sensex
| Date | Stock Price | Day Change | Sensex | Day Change |
|---|---|---|---|---|
| 2026-01-27 | Rs.400.40 | -5.35% | 35,786.84 | +0.50% |
| 2026-01-28 | Rs.402.25 | +0.46% | 36,188.16 | +1.12% |
| 2026-01-29 | Rs.414.25 | +2.98% | 36,266.59 | +0.22% |
| 2026-01-30 | Rs.417.95 | +0.89% | 36,185.03 | -0.22% |
Key Takeaways
Negative Financial Trends: The company’s quarterly results revealed a sharp decline in net sales by 21.96% and a 43.0% drop in profit after tax, signalling operational challenges and margin pressures. Rising interest expenses by 49.44% further strained profitability.
Stock Underperformance: The stock fell 1.21% over the week, significantly underperforming the Sensex’s 1.62% gain. The 52-week low of Rs.381.10 on 27 January highlights the ongoing downtrend and investor caution.
Valuation and Leverage: Despite a low debt-to-EBITDA ratio of 0.47 times and a reasonable price-to-book value of 3.5, the company’s deteriorating financial metrics have overshadowed these positives.
Market Sentiment: The downgrade to a Strong Sell Mojo Grade with a low score of 23.0 reflects heightened risk perception and subdued investor confidence amid sector headwinds.
Conclusion
Shree Ganesh Remedies Ltd’s week was characterised by significant financial setbacks and a persistent downtrend in its share price. The stock’s fall to a 52-week low and the sharp quarterly earnings decline underscore the challenges the company faces in a competitive and volatile Pharmaceuticals & Biotechnology sector. While the broader market advanced steadily, the stock’s underperformance and negative financial trend score highlight cautionary signals for investors. The company’s modest leverage and valuation metrics provide some balance sheet stability, but the near-term outlook remains subdued given the current earnings pressures and sector dynamics.
Unlock special upgrade rates for a limited period. Start Saving Now →
